3.41
10.36%
0.32
시간 외 거래:
3.45
0.04
+1.17%
전일 마감가:
$3.09
열려 있는:
$3.16
하루 거래량:
7.50M
Relative Volume:
1.74
시가총액:
$1.40B
수익:
$4.78B
순이익/손실:
$-284.68M
주가수익비율:
-4.942
EPS:
-0.69
순현금흐름:
$-184.84M
1주 성능:
+24.00%
1개월 성능:
+73.10%
6개월 성능:
-50.51%
1년 성능:
-46.47%
애질론 헬스 Stock (AGL) Company Profile
명칭
Agilon Health Inc
전화
562-256-3800
주소
6210 E HWY 290, AUSTIN
AGL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
3.41 | 1.40B | 4.78B | -284.68M | -184.84M | -0.69 |
HCA
Hca Healthcare Inc
|
318.47 | 80.67B | 69.62B | 5.93B | 5.88B | 22.27 |
DVA
Davita Inc
|
169.97 | 14.91B | 12.67B | 827.68M | 1.42B | 9.27 |
FMS
Fresenius Medical Care Ag Adr
|
23.09 | 13.55B | 20.87B | 715.14M | 1.67B | 1.2209 |
THC
Tenet Healthcare Corp
|
134.43 | 13.13B | 20.97B | 3.13B | 2.39B | 31.21 |
UHS
Universal Health Services Inc
|
188.78 | 12.45B | 15.42B | 1.03B | 956.84M | 15.02 |
애질론 헬스 Stock (AGL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-10 | 업그레이드 | Citigroup | Sell → Neutral |
2025-01-10 | 개시 | Needham | Hold |
2024-12-16 | 개시 | Macquarie | Neutral |
2024-12-11 | 개시 | Bernstein | Mkt Perform |
2024-11-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2024-10-30 | 다운그레이드 | Citigroup | Neutral → Sell |
2024-10-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
2024-05-30 | 개시 | Robert W. Baird | Neutral |
2024-04-22 | 개시 | Citigroup | Neutral |
2024-03-06 | 개시 | Barclays | Underweight |
2024-02-26 | 다운그레이드 | Jefferies | Buy → Hold |
2024-02-26 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
2024-01-08 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2024-01-08 | 다운그레이드 | Stifel | Buy → Hold |
2024-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2024-01-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2024-01-05 | 다운그레이드 | Truist | Buy → Hold |
2023-12-11 | 다운그레이드 | Goldman | Buy → Neutral |
2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
2023-11-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2023-10-20 | 개시 | The Benchmark Company | Buy |
2023-06-13 | 개시 | Evercore ISI | In-line |
2022-12-09 | 개시 | Stifel | Buy |
2022-09-14 | 개시 | RBC Capital Mkts | Outperform |
2022-09-12 | 개시 | Goldman | Buy |
2022-09-07 | 재개 | Truist | Buy |
2022-06-24 | 개시 | BTIG Research | Neutral |
2022-03-30 | 개시 | Guggenheim | Buy |
2021-10-20 | 개시 | Jefferies | Buy |
2021-09-27 | 개시 | SVB Leerink | Outperform |
2021-09-10 | 개시 | Cowen | Outperform |
2021-05-11 | 개시 | William Blair | Outperform |
2021-05-10 | 개시 | BofA Securities | Buy |
2021-05-10 | 개시 | Deutsche Bank | Buy |
2021-05-10 | 개시 | Goldman | Buy |
2021-05-10 | 개시 | JP Morgan | Overweight |
2021-05-10 | 개시 | Truist | Buy |
2021-05-10 | 개시 | Wells Fargo | Overweight |
2021-05-10 | 개시 | Wolfe Research | Outperform |
모두보기
애질론 헬스 주식(AGL)의 최신 뉴스
agilon health validates InvestingPro's Fair Value analysis with 60% rally - MSN
agilon health validates InvestingPro's Fair Value analysis with 60% rally By Investing.com - Investing.com Canada
Analysts Set agilon health, inc. (NYSE:AGL) PT at $4.03 - MarketBeat
agilon health (NYSE:AGL) Trading 8.5% Higher on Analyst Upgrade - MarketBeat
Here’s Why Analysts Just Upgraded Agilon Health (AGL) - MSN
Market-Perform maintained for agilon health stock amid cash flow prudence - Investing.com India
Sanford C. Bernstein Increases agilon health (NYSE:AGL) Price Target to $3.15 - MarketBeat
Further Upside For agilon health, inc. (NYSE:AGL) Shares Could Introduce Price Risks After 29% Bounce - Simply Wall St
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies - Investing.com Australia
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Trading Up 6.4%Time to Buy? - MarketBeat
Citigroup Upgrades agilon health (AGL) - MSN
Commit To Buy Agilon Health At $2, Earn 37.5% Using Options - Nasdaq
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective - Investing.com India
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Earns Hold Rating from Analysts at Needham & Company LLC - MarketBeat
agilon health (NYSE:AGL) Shares Up 9.6%Here's What Happened - MarketBeat
Securities Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against agilon health, inc. - AccessWire
Short Interest in agilon health, inc. (NYSE:AGL) Declines By 6.7% - MarketBeat
agilon health, inc. (NYSE:AGL) Position Cut by Stifel Financial Corp - Defense World
Agilon Health, Inc, B. Riley Financial, Target Corporation, - GlobeNewswire
Agilon Health, Inc, B. Riley Financial, Target Corporation, and Getty Images Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
agilon health, inc. (NYSE:AGL) Receives $4.28 Consensus Target Price from Analysts - MarketBeat
agilon health (NYSE:AGL) Trading Down 5.8%Here's Why - MarketBeat
agilon health Slides As Insider Purchases Lose Another US$50k - Simply Wall St
agilon health (NYSE:AGL) Trading 5% HigherWhat's Next? - MarketBeat
AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc.AGL - The Eastern Progress Online
agilon health (NYSE:AGL) Stock Price Down 7.8%Here's Why - MarketBeat
Forecasting The Future: 10 Analyst Projections For Agilon Health - Benzinga
agilon health, inc. (NYSE:AGL) Short Interest Update - MarketBeat
agilon health (NYSE:AGL) Now Covered by Analysts at Macquarie - MarketBeat
Macquarie starts agilon health at Neutral amid market challenges - Investing.com
Macquarie starts agilon health at Neutral amid market challenges By Investing.com - Investing.com South Africa
Agilon Health's SWOT analysis: stock faces challenges amid value-based care push - Investing.com
agilon health, inc. (NYSE:AGL) Director Purchases $55,000.00 in Stock - MarketBeat
Agilon Health director McLoughlin buys $55,084 in stock By Investing.com - Investing.com Canada
Agilon Health director McLoughlin buys $55,084 in stock - Investing.com India
Agilon Health director Silvana Battaglia acquires $50,269 in stock By Investing.com - Investing.com Australia
Agilon Health director Silvana Battaglia acquires $50,269 in stock - Investing.com
Bernstein Initiates Coverage of agilon health (AGL) with Market Perform Recommendation - MSN
Agilon health director Diana McKenzie buys $44,962 in common stock By Investing.com - Investing.com Nigeria
Agilon Health director Wulf John William buys $98,145 in stock By Investing.com - Investing.com Australia
Agilon Health director Wulf John William buys $98,145 in stock - Investing.com
애질론 헬스 (AGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):